20 results
424B3
IMUX
Immunic Inc
30 Apr 24
Prospectus supplement
5:16pm
Janus Henderson Biotech Innovation Master Fund Limited8
Soleus Private Equity Fund III, L.P.9
Soleus Capital Master Fund, LP10
Altium Growth Fund … -funded warrants held in the aggregate by RTW Master Fund, Ltd., RTW Innovation Master Fund, Ltd., and RTW Biotech Opportunities Ltd (the “RTW Funds
8-K
EX-99.1
IMUX
Immunic Inc
27 Apr 23
Departure of Directors or Certain Officers
6:40am
at Biogen as Director of the Value-Based Medicine Innovation Hub and Director of the Medical Evidence, Research and Innovation Unit. He has authored over
424B3
IMUX
Immunic Inc
20 Dec 22
Prospectus supplement
5:01pm
by RTW Master Fund, Ltd., RTW Innovation Master Fund, Ltd. and RTW Venture Fund Limited (collectively, the “RTW Funds”) as of November 30, 2022. RTW
8-K
EX-99.1
8mrzhyp
20 Oct 20
EIB Provides Immunic With up to €24.5 Million to Support Ongoing Development of a Potential COVID-19 Therapy
7:19am
424B3
ugal32wd7tfnvwshj
19 Feb 19
Prospectus supplement
5:03pm
S-4/A
vi8ga269h2sgryar
14 Feb 19
Registration of securities issued in business combination transactions (amended)
9:02am
S-4
8r8752t8jujjh
4 Feb 19
Registration of securities issued in business combination transactions
5:58pm
425
q4mhbz
7 Jan 19
Business combination disclosure
4:41pm
DEF 14A
vbgdqhikz2cpt
7 Oct 15
Definitive proxy
12:00am
10-K
vnipn2
20 Mar 15
Annual report
12:00am
424B4
t62j4tgka80
3 Oct 14
Prospectus supplement with pricing info
12:00am
424B4
w6xdt6 i7nbkbkal56
17 Apr 14
Prospectus supplement with pricing info
12:00am
- Prev
- 1
- Next